Welcome to our dedicated page for PLMKU news (Ticker: PLMKU), a resource for investors and traders seeking the latest updates and insights on PLMKU stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PLMKU's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PLMKU's position in the market.
Plum Acquisition Corp. IV has announced the pricing of its initial public offering (IPO) of 15,000,000 units at $10.00 per unit on January 14, 2025. The units will trade on the Nasdaq Global Market under symbol 'PLMKU' starting January 15, 2025.
Each unit comprises one Class A ordinary share and one-half redeemable warrant. Each whole warrant allows purchase of one Class A ordinary share at $11.50 per share. Upon separate trading, shares and warrants will trade under 'PLMK' and 'PLMKW' respectively.
The company aims to pursue business combinations across any sector, leveraging management's expertise and relationships. Cohen & Company Capital Markets leads the offering, with Seaport Global Securities as joint book-runner. Underwriters have a 45-day option to purchase up to 2,250,000 additional units for over-allotments.
